Economy

Analyst Opinion Summary: CVS Health Corporation (CVS), Sandstorm Gold Ltd. (NYSEAmerican:SAND)

CVS Health Corporation (NYSE:CVS) tinted gains of +0.55% (+0.38 points) to US$69.38. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator's stock valued at $117,000 after buying an additional 741 shares in the last quarter. CVS Health Corporation makes up approximately 1.5% of GFS Advisors LLC's investment portfolio, making the stock its 18th largest position. Oppenheimer Holdings, Inc. restated a "buy" rating and set a $95.00 price objective on shares of CVS Health Corporation in a research note on Monday, October 9th.

Driving interest in CVS Health Corporation (CVS) is a number of factors, including perhaps, a steady decrease of the profile of the company as insider activity takes center stage. Arcadia Investment Management Corp MI now owns 1,605 shares of the pharmacy operator's stock valued at $154,000 after buying an additional 750 shares in the last quarter. The stock now has Weekly Volatility of 3.40% and Monthly Volatility of 2.83%. Eagle Ridge Investment Management raised its position in CVS Health Corporation by 3.7% during the 1st quarter. The company's institutional ownership is monitored at 84.6 percent. Mai Cap Mgmt reported 0.49% of its portfolio in CVS Health Corp (NYSE:CVS).

CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, August 8th. Recently, analysts have updated the overall rating to 2.2. Royal Bank Of Canada began coverage on CVS Health Corporation in a report on Tuesday, September 19th. As per Wednesday, August 16, the company rating was downgraded by Wolfe Research. The company has market cap of $70.40 billion.

CVS Health Corporation was covered by a number of analysts recently, 5 rated the stock as Buy, 10 rated Hold, 0 rated sell and 0 gave an Underperform.

Analysts on average have given a price target of $86.75 to CVS Health Corporation (CVS) stock. Finally, Guggenheim restated a buy rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. The shares were sold at an average price of $83.07, for a total transaction of $20,032,330.50. Tributary Capital Mngmt Limited Liability Company owns 4,600 shares.

Active and passive investors always require every bit of information available regarding his chosen security and this include keeping close watch on fundamental and technical data. This activity has been headed largely by Thomas Moriarty, an officer of the company. The stock presently has an average rating of "Buy" and an average price target of $112.02. 6,502,788 shares of the company's stock were exchanged. The disclosure for this sale can be found here.

Investors saw a negative move of -5.36% in last five trading days.

TRADEMARK VIOLATION NOTICE: "CVS Health Corporation (CVS) Shares Bought by GFS Advisors LLC" was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this story on another site, it was stolen and republished in violation of USA & global copyright legislation. The original version of this piece of content can be read at https://www.truebluetribune.com/2017/11/03/cvs-health-corporation-cvs-downgraded-by-thestreet.html. Equities analysts expect that CVS Health Corporation will post $5.86 earnings per share for the current year. After $1.33 actual earnings per share reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 12.03% EPS growth. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. Comparatively, CVS posted earnings of $1.95 per share in the same quarter, a year earlier. In contrast to the year ago quarter EPS was at 1.53. The firm earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be issued a $0.50 dividend. This represents a $1.70 annualized dividend and a yield of 1.97%. The ex-dividend date is Monday, October 23rd. Currently CVS Health Corporation (CVS) stock is moving with downswing trend.

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate.

Want to see what other hedge funds are holding CVS?



Like this

Latest


04 November 2017
Stephen Hawking says robots will eventually outperform and replace humans
We can not predict what we might achieve, when our own minds are amplified by AI. "And surely we will aim to finally eradicate disease and poverty.

03 November 2017
Kroger shares rise on clothing push
So while it could be years away, you might stock up on jeans and t-shirts along with meats and veggies at Kroger. European grocers Aldi and Lidi plan to open stores in the United States - another looming threat for Kroger.

03 November 2017
GOP Rep. Introduces Resolution Calling On Mueller To Resign From Russia Probe
Clinton was secretary of state when the deal was approved, but she did not have sole power over the deal. Mueller was the director of the Federal Bureau of Investigation ".

03 November 2017
Cisco Systems Inc. (CSCO) Given Buy Rating at Deutsche Bank AG
Finally, Baystate Wealth Management LLC increased its holdings in shares of Cisco Systems by 24.5% during the first quarter. Gibraltar Cap Inc accumulated 99,031 shares or 3.1% of the stock. 10,899 were reported by Bankshares Of Nova Scotia Com.

03 November 2017
Pirates pick up 2018 option on Andrew McCutchen
If he plays with the Pirates in 2018, it will mark his 10th season with the team, which drafted him 11th overall in 2005. McCutchen had a.279 batting average, 28 home runs and 88 RBI during an up-and-down 2017 season.

03 November 2017
Dicerna Pharmaceuticals, Inc. (DRNA) Receives Buy Rating from HC Wainwright
This works out to a net increase in ownership of 42912 shares, and suggests that institutions are feeling bullish about the stock. DRNA is now overvalued by 25.74% relative to the average 1-year price target of $5.75 taken from a group of Wall Street Analysts.

03 November 2017
Government Makes FASTag Mandatory For Cars From December 1
The onus of buying a FASTag is not on the owner of the vehicle anymore and has been passed on to dealers and manufacturers. Issuer Agency will electronically deduct the applicable toll fee from the customer's account linked to the FASTag.

03 November 2017
Analyst Commentary On Tenet Healthcare Corp. (THC), Nokia Corporation (NOK)
The company now has a Return on Equity of -44.6% and a Return on Investment of 7.4%. 168,300 were reported by Swiss Bank & Trust. Technical Analysis: The Company has the market capitalization of $1.44B. (HPQ) to generate earnings per share of $1.65 in 2017.

03 November 2017
As Terror Strikes New York, India-US Vow to Increase Cooperation
Some administration officials are expected to be interviewed by Mueller's team while Trump is on a 12-day trip to Asia. According to a source, advisers in the West Wing are on edge and doing whatever they cannot to be ensnared.

03 November 2017
Bridge Bancorp, Inc. (BDGE) Receives $38.50 Consensus Target Price from Analysts
Piper Jaffray Cos. restated an "overweight" rating and set a $47.00 price objective (up previously from $46.00) on shares of U.S. It improved, as 41 investors sold CE shares while 138 reduced holdings. 18 funds opened positions while 44 raised stakes.